Related Experiment Videos

Transplacental immunity to varicella-zoster virus in extremely low birthweight infants

D B Mendez1, M B Sinclair, S Garcia

  • 1Department of Pediatrics, Wyler Children's Hospital, University of Chicago, Illinois.

Insights

Extremely premature infants may possess protective antibodies against chickenpox (varicella-zoster virus). This study found that most infants in intensive care had sufficient varicella-zoster virus antibody levels, suggesting passive immunity transfer.

Area of Science:

  • Neonatalogy
  • Immunology
  • Infectious Diseases

Background:

  • Infants in intensive care nurseries (ICN) face unique health risks.
  • Exposure to chickenpox (varicella-zoster virus, VZV) in premature infants is a concern due to potential lack of transplacental antibody transfer.
  • Premature infants, especially those with low birthweights or early gestational ages, are particularly vulnerable.

Purpose of the Study:

  • To investigate the presence and levels of VZV antibodies in premature infants following inadvertent exposure.
  • To determine if passive immunity to VZV is effectively transferred to extremely premature neonates.
  • To assess the risk of VZV infection in this vulnerable population.

Main Methods:

  • Serum samples were collected from 16 infants in an ICN after exposure to an adult with chickenpox.
  • Indirect fluorescent antibody testing was used to detect and quantify VZV antibody levels.
  • Infants were categorized by birthweight (≤1000 gm) and gestational age (≤28 weeks).

Main Results:

  • Fourteen out of 16 infants demonstrated VZV antibody levels of 1:16 or higher.
  • Six of eight infants weighing ≤1000 gm had adequate antibody levels.
  • Eight of ten infants with gestational ages ≤28 weeks possessed sufficient VZV antibodies.

Conclusions:

  • Passive transfer of immunity to VZV is common even in very premature infants (24-28 weeks' gestation).
  • This suggests that extremely premature neonates may have a degree of protection against VZV infection.
  • Further research may explore the clinical implications of this passive immunity in neonatal intensive care settings.

Related Concept Videos